
NVDA
NVIDIA Corporation
43
Building
NVIDIA converts the AI capex buildout into record margins, yet export controls and custom silicon cap a medium-conviction setup.
The thesis
NVIDIA sells the GPUs that hyperscaler AI spending flows through, and its data centre segment carried fiscal 2025 revenue. Revenue grew 105.8% year over year, gross margin sits at 74.7%, and net margin reaches 63.7%. Analysts rate the stock a consensus buy at 26.7x earnings, a modest multiple for that growth rate. Our conviction score is only 53 of 100 because export controls and custom ASIC competition contradict the clean bull case.
Why now
Chinese tech giants ordered $35 billion of compliant NVIDIA chips, directly testing how much restricted demand converts into revenue. Meanwhile China's export restrictions on indium processing remind the market that the supply chain itself is a policy variable, so the trade backdrop is shifting faster than the consensus narrative.
What to watch
Data centre revenue sequencing and gross margin movement over the next two quarters, which will show whether compliant China chips actually ship at the ordered $35 billion scale. Any new accelerator export restriction, plus hyperscaler capex commentary and custom silicon win rates, will confirm or deny the durability of NVIDIA's share of AI spend.
Key risks
Export controls can truncate the China order book again after compliance criteria change. Custom ASICs and AMD pressure the accelerator market where NVIDIA's 74.7% gross margin implies pricing power that competition may erode. A pause in hyperscaler AI capex would cut the primary revenue driver.
Theme exposure
Semiconductors & AI Compute
DirectNVIDIA dominates the AI accelerator market with its H100/H200/Blackwell GPU architecture. Hyperscaler AI training and inference capital expenditure flows directly to GPU revenue. NVIDIA's data centre segment accounted for the majority of fiscal 2025 revenue.
This brief is generated from our intelligence layers. Treat it as a starting point, not a final word.
Market intelligence only. Not financial advice. Not a recommendation.